|
|
|
Volumn 33, Issue 32, 2003, Pages 36-37
|
|
Injecting some hope. Cell therapy could lead to new treatments for congestive heart failure, whose sufferers now have few options.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
AUTOTRANSPLANTATION;
BIOTECHNOLOGY;
CARDIOLOGY;
CONGESTIVE HEART FAILURE;
ECONOMICS;
HEALTH CARE COST;
HUMAN;
PHASE 1 CLINICAL TRIAL;
SKELETAL MUSCLE SATELLITE CELL;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION;
UNITED STATES;
BIOTECHNOLOGY;
CARDIOLOGY;
CLINICAL TRIALS, PHASE I;
HEALTH CARE COSTS;
HEART FAILURE, CONGESTIVE;
HUMANS;
SATELLITE CELLS, SKELETAL MUSCLE;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION, AUTOLOGOUS;
UNITED STATES;
|
|
EID: 0141446232
PISSN: 01607480
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
